| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.44 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |